Search for: "Wyeth Pharmaceuticals"
Results 641 - 660
of 971
Sorted by Relevance
|
Sort by Date
23 Oct 2008, 10:31 am
" They asserted that if the Supreme Court endorses preemption by ruling in favor of Wyeth, "patients will lose an irreplaceable method for seeking remedies for injuries resulting from pharmaceutical agents that were approved by FDA. [read post]
28 Jul 2009, 5:50 pm
Our pharmaceutical injury attorneys help patients and their families hold drug manufacturers legally liable for injuries caused by flaws in their medication, or lack of warning about potentially dangerous side effects. [read post]
27 Sep 2011, 2:31 pm
Wyeth followed suit, holding that state law failure-to-warn claims against generic pharmaceutical manufacturers were pre-empted by federal law. [read post]
7 Jan 2011, 11:41 am
The rationale behind passage of the Act was the fear that pharmaceutical companies would stop manufacturing vaccines if they were exposed to litigation for defective vaccines. [read post]
7 Jan 2011, 11:41 am
The rationale behind passage of the Act was the fear that pharmaceutical companies would stop manufacturing vaccines if they were exposed to litigation for defective vaccines. [read post]
22 Jul 2009, 10:59 am
As we saw in the Wyeth v. [read post]
9 Mar 2009, 7:06 am
The Court, following up on its ruling last week in Wyeth v. [read post]
10 Jun 2014, 10:11 am
The four concurring Justices are the same four who disagreed with the Court’s decision in Wyeth v. [read post]
7 Nov 2014, 5:52 am
Teva Pharmaceuticals USA, Inc., 819 F. [read post]
27 Oct 2011, 4:24 am
The Supreme Court held in Wyeth v. [read post]
21 Jun 2012, 4:30 am
Wyeth Labs., 498 F.2d 1264, 1276 (5th Cir. 1974). [read post]
5 Aug 2009, 5:35 am
(Spicy IP) Coversyl (Perindopril) – Canada: Court of Appeal upholds Trial Division finding of patent validity and infringement: Apotex v ADIR (Pharmacapsules@Gowlings) Cozaar (Losartan) – France: French Patent Office grants paediatric extension of French SPC for Losartan (The SPC Blog) Cozaar/Hyzaar (Losartan) – US: FDA prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva Pharmaceuticals v Sebelius (FDA Law Blog) Diflucan… [read post]
27 May 2010, 3:20 am
Anchen Pharmaceuticals Inc et al. [read post]
13 Jul 2011, 3:04 am
(The SPC Blog) Doha+10: On November 14, 2011, a meeting at WIPO in Geneva to discuss the Doha Declaration (KEI) Docs at BIO: Session on IP challenges for personalised medicine (Patent Docs) France to reform its pharmaceutical regulatory system… with possible global implications! [read post]
13 May 2010, 4:58 pm
Watson Pharmaceuticals Inc. et al. [read post]
24 Jun 2013, 12:50 pm
Wyeth, 619 F.3d 632 (6th Cir. 2010), is no longer good law for the proposition that earned it that ranking. [read post]
12 Mar 2015, 5:33 am
Based on the foregoing, the Court concludes that the FDCA occupies the field of importation of pharmaceuticals from foreign countries.Ouellette, 2015 WL 751760, at *7 (footnote omitted). [read post]
28 Nov 2013, 5:00 am
Wyeth Pharmaceuticals, Inc., 15 A.3d 909, 935 n.17 (Pa. [read post]
17 Sep 2015, 3:01 pm
Wyeth, Inc., 85 Cal. [read post]
7 Jan 2015, 6:54 am
As to design defect preemption, Yatesalso explained that Wyeth v. [read post]
